{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:05:47Z","timestamp":1790813147332,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T00:00:00Z","timestamp":1628121600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016714","name":"University of Sharjah","doi-asserted-by":"publisher","award":["REC-21-02-09-07"],"award-info":[{"award-number":["REC-21-02-09-07"]}],"id":[{"id":"10.13039\/100016714","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.ijid.2021.08.013","type":"journal-article","created":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T13:06:44Z","timestamp":1628514404000},"page":"219-226","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":184,"special_numbering":"C","title":["Side effects and perceptions following Sinopharm COVID-19 vaccination"],"prefix":"10.1016","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3105-5501","authenticated-orcid":false,"given":"Balsam Qubais","family":"Saeed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rula","family":"Al-Shahrabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaikha Salah","family":"Alhaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7321-5374","authenticated-orcid":false,"given":"Zainab Mansour","family":"Alkokhardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Omar","family":"Adrees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2021.08.013_bib0001","doi-asserted-by":"crossref","first-page":"e13891","DOI":"10.1111\/ijcp.13891","article-title":"While studies on COVID-19 vaccine is ongoing, the public's thoughts and attitudes to the future COVID-19 vaccine","volume":"75","author":"Akarsu","year":"2021","journal-title":"Int J Clin Pract"},{"issue":"20","key":"10.1016\/j.ijid.2021.08.013_bib0002","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects","volume":"310","author":"Arest\u00e9","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.ijid.2021.08.013_bib0003","doi-asserted-by":"crossref","first-page":"400","DOI":"10.18176\/jiaci.0562","article-title":"Delayed Hypersensitivity Reactions Caused by Drug Excipients: A Literature Review","volume":"30","author":"Caballero","year":"2020","journal-title":"J. Investig. Allergol. Clin. Immunol."},{"key":"10.1016\/j.ijid.2021.08.013_bib0004","unstructured":"CDC. 2020 https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/need-extra-precautions\/people-with-medical-conditions.html"},{"issue":"21","key":"10.1016\/j.ijid.2021.08.013_bib0005","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1001\/jama.2021.5374","article-title":"Reactogenicity Following Receipt of mRNA-Based COVID-19 Vaccines","volume":"325","author":"Chapin-Bardales","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.ijid.2021.08.013_bib0006","unstructured":"China State-Backed Covid Vaccine Has 86% Efficacy, UAE Says\". Bloomberg.com. 2020-12-09.2021 Retrieved 2020-12-09. https:\/\/www.bloomberg.com\/news\/articles\/2020-12-09\/uae-says-sinopharm-vaccine-has-86-efficacy-against-covid-19"},{"key":"10.1016\/j.ijid.2021.08.013_bib0007","unstructured":"China to run human coronavirus vaccine trial in UAE. Reuters. 2020; Jun https:\/\/www.reuters.com\/article\/us-health-coronavirus-china-vaccine\/china-to-run-human-coronavirus-vaccine-trial-in-uae-idUSKBN23U2H8."},{"key":"10.1016\/j.ijid.2021.08.013_bib0008","unstructured":"Coronavirus disease (COVID-19): How is it transmitted?. 2021, https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/question-and-answers-hub\/q-a-detail\/coronavirus-disease-covid-19-how-is-it-transmitted"},{"key":"10.1016\/j.ijid.2021.08.013_bib0009","unstructured":"COVID-19 Vaccine, Awareness Guide, April, 2021, https:\/\/www.dha.gov.ae\/Asset%20Library\/COVID19\/Covid19_Vaccine_EN.pdf"},{"issue":"7839","key":"10.1016\/j.ijid.2021.08.013_bib0010","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/d41586-020-03563-z","article-title":"Arab nations first to approve Chinese COVID vaccine \u2014 despite lack of public data","volume":"588","author":"Cyranoski","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ijid.2021.08.013_bib0011","unstructured":"Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2. 2021. Retrieved 1 June 2021, https:\/\/dx.doi.org\/10.1016%2Fj.cell.2020.06.008"},{"issue":"9596","key":"10.1016\/j.ijid.2021.08.013_bib0012","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"Elm","year":"2007","journal-title":"The Lancet"},{"key":"10.1016\/j.ijid.2021.08.013_bib0013","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.2147\/IJGM.S310497","article-title":"Minor to Moderate Side Effects of Pfizer-BioNTech COVID-19 Vaccine Among Saudi Residents: A Retrospective Cross-Sectional Stud","volume":"14","author":"El-Shitany","year":"2021","journal-title":"International Journal of General Medicine"},{"key":"10.1016\/j.ijid.2021.08.013_bib0014","unstructured":"Food and Health Bureau (FHB). Report on Evaluation of Safety, Efficacy and Quality of CoronaVac COVID-19 Vaccine (Vero Cell) Inactivated. 2021. Available online: https:\/\/www.fhb.gov.hk\/download\/our_work\/health\/201200\/e_evaluation_report_CoronaVac.pdf"},{"key":"10.1016\/j.ijid.2021.08.013_bib0015","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/s41418-020-00720-9","article-title":"COVID-19 Commission of Accademia Nazionale deiLincei, Rome. COVID-19 vaccines: Where we stand and challenges ahead","volume":"28","author":"Forni","year":"2021","journal-title":"Cell Death Differ"},{"issue":"12","key":"10.1016\/j.ijid.2021.08.013_bib0016","first-page":"1201","article-title":"Resolution of coronavirus disease 2019 (COVID-19)","volume":"18","author":"Habas","year":"2020","journal-title":"ERATCK"},{"issue":"1","key":"10.1016\/j.ijid.2021.08.013_bib0017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4062\/biomolther.2020.178","article-title":"COVID-19 Vaccine: Critical Questions with Complicated Answers","volume":"29","author":"Haidere","year":"2021","journal-title":"Biomol Ther"},{"key":"10.1016\/j.ijid.2021.08.013_bib0018","doi-asserted-by":"crossref","first-page":"556","DOI":"10.3390\/vaccines9060556","article-title":"Side Effects and Perceptions Following COVID-19 Vaccination in Jordan: A Randomized, Cross-Sectional Study Implementing Machine Learning for Predicting Severity of Side Effects","volume":"9","author":"Hatmal","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.ijid.2021.08.013_bib0019","unstructured":"Henley J; Guardian correspondents. Coronavirus causing some anti-vaxxers to waver, experts say; 2020. https:\/\/www.theguardian.com\/world\/2020\/apr\/21\/anti-vaccination-community-divided-how-respond-to-coronavirus-pandemic. Accessed July 27, 2020."},{"issue":"39","key":"10.1016\/j.ijid.2021.08.013_bib0020","article-title":"The how's and what's of vaccine reactogenicity","volume":"4","author":"Herv\u00e9","year":"2019","journal-title":"npj Vaccines"},{"key":"10.1016\/j.ijid.2021.08.013_bib0021","doi-asserted-by":"crossref","unstructured":"Jayadevan R, Shenoy R, Anithadevi TS. Survey of symptoms following COVID-19 vaccination in India.2021 medRxiv preprint doi: https:\/\/doi.org\/10.1101\/2021.02.08.21251366.","DOI":"10.1101\/2021.02.08.21251366"},{"key":"10.1016\/j.ijid.2021.08.013_bib0022","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ijid.2021.04.047","article-title":"Side effects of BNT162b2 mRNA COVID-19 vaccine: A randomized, cross-sectional study with detailed self-reported symptoms from healthcare workers","volume":"106","author":"Kadali","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.ijid.2021.08.013_bib0023","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S1473-3099(10)70049-9","article-title":"The Xs and Y of immune responses to viral vaccines","volume":"10","author":"Klein","year":"2010","journal-title":"Lancet Infect. Dis."},{"issue":"Suppl. 3","key":"10.1016\/j.ijid.2021.08.013_bib0024","doi-asserted-by":"crossref","first-page":"S114","DOI":"10.1093\/infdis\/jiu066","article-title":"Sex-based biology and the rational design of influenza vaccination strategies","volume":"209","author":"Klein","year":"2014","journal-title":"J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.ijid.2021.08.013_bib0025","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3390\/vaccines9030221","article-title":"Allergic Reactions to Current Available COVID-19 Vaccinations: Pathophysiology, Causality, and Therapeutic Considerations","volume":"9","author":"Kounis","year":"2021","journal-title":"Vaccines"},{"issue":"3","key":"10.1016\/j.ijid.2021.08.013_bib0026","article-title":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges","volume":"55","author":"Lai","year":"2020","journal-title":"Agents"},{"key":"10.1016\/j.ijid.2021.08.013_bib0027","unstructured":"Latimer K. About 20% of people in recent survey said they wouldn't take COVID-19 vaccine; 2020. https:\/\/www.cbc.ca\/news\/canada\/saskatchewan\/covid-survey-first-round-results-1.5541053. Accessed July 27, 2020."},{"issue":"3","key":"10.1016\/j.ijid.2021.08.013_bib0028","doi-asserted-by":"crossref","first-page":"276","DOI":"10.11613\/BM.2012.031","article-title":"Interrater reliability: the kappa statistic","volume":"22","author":"McHugh","year":"2012","journal-title":"Biochem Med (Zagreb)"},{"key":"10.1016\/j.ijid.2021.08.013_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(21)00224-3","article-title":"Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: A prospective observational study","author":"Menni","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ijid.2021.08.013_bib0030","first-page":"248","article-title":"The Assessment of Reliability","volume":"3","author":"Nunnally","year":"1994","journal-title":"Psychometric Theory"},{"issue":"suppl 2","key":"10.1016\/j.ijid.2021.08.013_bib0031","article-title":"Barriers affecting compliance of patients with chronic diseases: A preliminary study in United Arab Emirates (UAE) population","volume":"4","author":"Osama","year":"2011","journal-title":"AJPCR"},{"issue":"4","key":"10.1016\/j.ijid.2021.08.013_bib0032","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s40264-020-01023-1","article-title":"Correction to: Assessing the Safety of COVID-19 Vaccines: A Primer","volume":"44","author":"Petousis-Harris","year":"2021","journal-title":"Drug Saf"},{"key":"10.1016\/j.ijid.2021.08.013_bib0033","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2021.08.013_bib0034","unstructured":"Possible Side Effects After Getting a COVID-19 Vaccine 2021. Available online: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/vaccines\/expect\/after.html (accessed on 25 April 2021)."},{"issue":"6","key":"10.1016\/j.ijid.2021.08.013_bib0035","doi-asserted-by":"crossref","first-page":"566","DOI":"10.3390\/vaccines9060566","article-title":"Global Prevalence and Drivers of Dental Students\u2019 COVID-19 Vaccine Hesitancy","volume":"9","author":"Riad","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.ijid.2021.08.013_bib0036","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.3390\/jcm10071428","article-title":"Prevalence of COVID-19 Vaccine Side Effects among Healthcare Workers in the Czech Republic. 2021","volume":"10","author":"Riad","year":"2021","journal-title":"J. Clin. Med."},{"issue":"12","key":"10.1016\/j.ijid.2021.08.013_bib46","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.3390\/jcm10122629","article-title":"Prevalence and Risk Factors of CoronaVac Side Effects: An Independent Cross-Sectional Study among Healthcare Workers in Turkey.","volume":"10","author":"Riad","year":"2021","journal-title":"J. Clin. Med."},{"issue":"12","key":"10.1016\/j.ijid.2021.08.013_bib0037","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.3390\/jcm10122629","article-title":"Prevalence and Risk Factors of CoronaVac Side Effects: An Independent Cross-Sectional Study among Healthcare Workers in Turkey","volume":"10","author":"Riad","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ijid.2021.08.013_bib0038","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.585354","article-title":"A Review of the Progress and Challenges of Developing a Vaccine for COVID-19","volume":"11","author":"Sharma","year":"2020","journal-title":"Front. Immunol"},{"key":"10.1016\/j.ijid.2021.08.013_bib0039","article-title":"Investigational treatments for COVID-19","author":"Trivedi","year":"2020","journal-title":"Pharm. J."},{"key":"10.1016\/j.ijid.2021.08.013_bib0040","unstructured":"World Health Organization (WHO): Evidence Assessment: Sinopharm\/BBIBP COVID-19 vaccine, for recommendation by the strategic advisory group of experts (sage) on immunization prepared by the sage working group on covid-19 vaccines. 2021"},{"issue":"10","key":"10.1016\/j.ijid.2021.08.013_bib0041","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1001\/jama.2020.15543","article-title":"Effect of an inactivated vaccine against SARS-CoV-2 on safety and immunogenicity outcomes: Interim analysis of 2 randomized clinical trials","volume":"324","author":"Xia","year":"2021","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ijid.2021.08.013_bib0044","first-page":"225","article-title":"A review on COVID-19 vaccines: stages of clinical trials, mode of actions and efficacy","volume":"28","author":"Zahid","year":"2021","journal-title":"Arab. J. Basic Appl. Sci."},{"issue":"2","key":"10.1016\/j.ijid.2021.08.013_bib0045","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S1473-3099(20)30843-4","article-title":"Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18\u201359 years: a randomised, double-blind, placebo-controlled, phase 1\/2 clinical trial","volume":"21","author":"Zhang","year":"2021","journal-title":"Lancet Infect Dis"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971221006469?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971221006469?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T13:25:26Z","timestamp":1778592326000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971221006469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":44,"alternative-id":["S1201971221006469"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2021.08.013","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.06.28.21258847","asserted-by":"object"}]},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Side effects and perceptions following Sinopharm COVID-19 vaccination","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2021.08.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}